Coronary bypass surgery: what is changing? Analysis of 3834 patients undergoing primary isolated myocardial

L Noyez1, D P Janssen, J A van Druten

  • 1Department of Thoracic and Cardiac Surgery, University Hospital Nijmegen, Netherlands. L.Noyez@thchir.azn.nl

Insights

Older patients with more co-existing conditions are increasingly undergoing myocardial revascularization. While hospital mortality remains stable, major postoperative morbidity has significantly increased in this evolving patient population.

Area of Science:

  • Cardiovascular Surgery
  • Clinical Outcomes Research
  • Epidemiology of Cardiac Disease

Background:

  • The patient demographic undergoing myocardial revascularization has shifted.
  • Understanding these demographic changes is crucial for quality control and economic decision-making in cardiac surgery.
  • Assessing the impact of these changes on morbidity and mortality is essential for future research.

Purpose of the Study:

  • To analyze trends in patient characteristics and outcomes for myocardial revascularization.
  • To evaluate the influence of demographic shifts on postoperative morbidity and mortality.
  • To provide data supporting informed decision-making in coronary artery surgery.

Main Methods:

  • Retrospective analysis of 3834 primary isolated coronary artery bypass graft operations.
  • Data collected from January 1987 to December 1995.
  • Patients divided into three time cohorts: 1987-1989, 1990-1992, and 1993-1995.

Main Results:

  • Mean patient age increased significantly from 60.4 to 62.9 years.
  • Significant increases observed in patients with diabetes, pulmonary, neurological, and uro-nephrological conditions.
  • Use of arterial grafts increased; hospital mortality remained stable at approximately 2.5%, but postoperative pulmonary, neurological, and uro-nephrological complications rose significantly.

Conclusions:

  • Myocardial revascularization is increasingly performed on older patients with more comorbidities.
  • Despite stable hospital mortality rates, there is a notable increase in major postoperative morbidity.
  • These findings highlight the evolving complexity of patients undergoing coronary artery bypass surgery.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...